PE/Cy7 anti-mouse CD49b (pan-NK cells)

Antibodies Single
Sony
DX5
Flow Cytometry
Rat IgM, κ
Mouse
IL-2-propagated NK1.1<SUP>+</SUP> cells from C57BL/6 mice
1144610
$260.00

Description

DX5 antigen has been recently characterized as CD49b. It is a 150 kD integrin α chain also known as α2 integrin, VLA-2 α chain, and integrin α2 chain. CD49b non-covalently associates with CD29 (β1 integrin) to form the CD49b/CD29 complex known as VLA-2, a receptor for collagen and laminin. CD49b is expressed on platelets, the majority of NK cells, NKT cells, and a small subset of CD8+ T cells (this population can be significantly increased following viral infection). DX5 is used for the identification and isolation of NK cells, and is especially useful for identifying NK cells in mice lacking the NK1.1 antigen.

Formulation

Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.5 microg per million cells in 100 microL volume.  It is recommended that the reagent be titrated for optimal performance for each application.

References

1. Arase H, et al. 2001. J. Immunol. 167:1141. (FC)
2. Sepulveda H, et al. 1999. J. Immunol. 163:1133.
3. Norian LA and Allen PM. 2004. J. Immunol. 173:835. (FC)
4. Andoniou CE, et al. 2005. Nature Immunology 6:1011.
5. Oertelt S, et al. 2006. J. Immunol. 177:1655. (IHC) PubMed
6. Bourdeau A, et al. 2007. Blood doi:10.1182/blood-2006-08-044370.
7. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
8. Qui Q, et al. 2010. J. Immunol. 184:1681. (FC) PubMed
9. Busche A, et al. 2011. J. Immunol. 186:2918. PubMed
10. Kim HR, et al. 2011. Nephrology 16:545. (IHC) PubMed
11. Seyoum B, et al. 2011. Vaccine. 29:8002. PubMed
12. Younos IH, et al. 2012. Int Immunopharmacol. 13:245. PubMed
13. Honjo K, et al. 2012. PNAS. PubMed
14. Byrne WL, et al. 2014. J Control Release. 196:384. PubMed
15. Drees J, et al. 2015. Anticancer Res. 35:843. PubMed